JP2008500009A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500009A5 JP2008500009A5 JP2006532309A JP2006532309A JP2008500009A5 JP 2008500009 A5 JP2008500009 A5 JP 2008500009A5 JP 2006532309 A JP2006532309 A JP 2006532309A JP 2006532309 A JP2006532309 A JP 2006532309A JP 2008500009 A5 JP2008500009 A5 JP 2008500009A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45188403P | 2003-03-03 | 2003-03-03 | |
| PCT/US2004/006460 WO2005051988A2 (en) | 2003-03-03 | 2004-03-02 | Compositions and methods for the treatment of systemic lupus erythematosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010089887A Division JP2010207229A (ja) | 2003-03-03 | 2010-04-08 | 全身性エリテマトーデスの治療のための組成物と方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008500009A JP2008500009A (ja) | 2008-01-10 |
| JP2008500009A5 true JP2008500009A5 (enExample) | 2009-05-14 |
Family
ID=34632721
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006532309A Pending JP2008500009A (ja) | 2003-03-03 | 2004-03-02 | 全身性エリテマトーデスの治療のための組成物と方法 |
| JP2010089887A Pending JP2010207229A (ja) | 2003-03-03 | 2010-04-08 | 全身性エリテマトーデスの治療のための組成物と方法 |
| JP2013121971A Pending JP2013240329A (ja) | 2003-03-03 | 2013-06-10 | 全身性エリテマトーデスの治療のための組成物と方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010089887A Pending JP2010207229A (ja) | 2003-03-03 | 2010-04-08 | 全身性エリテマトーデスの治療のための組成物と方法 |
| JP2013121971A Pending JP2013240329A (ja) | 2003-03-03 | 2013-06-10 | 全身性エリテマトーデスの治療のための組成物と方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7749695B2 (enExample) |
| EP (1) | EP1599498A2 (enExample) |
| JP (3) | JP2008500009A (enExample) |
| AU (2) | AU2004293369A1 (enExample) |
| CA (1) | CA2518101A1 (enExample) |
| WO (1) | WO2005051988A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020042062A1 (en) * | 1999-09-24 | 2002-04-11 | Mark Stearns | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| US7790861B2 (en) * | 1999-09-24 | 2010-09-07 | Philadelphia Health And Education Corporation | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| US7754435B2 (en) * | 2000-09-21 | 2010-07-13 | Philadelphia Health And Education Corporation | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| WO2007043103A1 (ja) * | 2005-09-30 | 2007-04-19 | Kansai Technology Licensing Organization Co., Ltd. | シェーグレン症候群診断法及び診断キット |
| EP2044213A2 (en) | 2006-04-24 | 2009-04-08 | Genentech, Inc. | Methods and compositions for detecting autoimmune disorders |
| CA2653071A1 (en) * | 2006-05-25 | 2007-12-06 | Sophie Brouard | Methods for diagnosing and treating graft rejection and inflammatory conditions |
| EP1905841A1 (en) * | 2006-09-25 | 2008-04-02 | Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; | Trex1 as a marker for lupus erythematosus |
| WO2010011965A2 (en) * | 2008-07-24 | 2010-01-28 | The Regents Of The University Of California | Identifying high risk clinically isolated syndrome patients |
| PT2473636T (pt) * | 2009-09-03 | 2017-02-06 | Medimmune Llc | Diagnóstico de interferão de tipo-1 |
| WO2012042480A1 (en) | 2010-09-28 | 2012-04-05 | Kahr Medical Ltd. | Compositions and methods for treatment of hematological malignancies |
| CN104334741B (zh) | 2012-03-28 | 2018-08-17 | 歌德塔有限公司 | 组合的γ9δ2T细胞受体链交换 |
| EP3469361B1 (en) | 2016-06-10 | 2024-07-31 | Gadeta B.V. | Novel method for identifying deltat-cell (or gammat-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response |
| JP2019535834A (ja) * | 2016-11-18 | 2019-12-12 | ユニベルシタ デ バルセロナ | 感染症及び関連炎症プロセスの処置のためのｃｄ６及びイミペネムの併用療法 |
| EP3583124A1 (en) | 2017-02-17 | 2019-12-25 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
| MX2020007336A (es) * | 2018-01-09 | 2021-01-15 | Imagine Pharma Llc | Metodos y composiciones para modular la disfuncion de celulas endoteliales. |
| GB202012804D0 (en) * | 2020-08-17 | 2020-09-30 | Univ London Queen Mary | Agrin polypeptide and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992016660A1 (en) * | 1991-03-22 | 1992-10-01 | Sloan-Kettering Institute For Cancer Research | Methods for detection and treatment of cancer |
| IL141551A0 (en) * | 1998-09-17 | 2002-03-10 | Genentech Inc | Compositions and methods for the treatment of immune related diseases |
| JP2004516227A (ja) * | 1999-03-08 | 2004-06-03 | ジェネンテック・インコーポレーテッド | 免疫関連疾患を治療するための組成物と方法 |
| JP2002543764A (ja) * | 1999-03-19 | 2002-12-24 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ４６個のヒト分泌タンパク質 |
| AU3434601A (en) * | 1999-11-30 | 2001-06-12 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
| EP1240325B1 (en) * | 1999-12-23 | 2009-09-30 | Genentech, Inc. | Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| EP1572987A4 (en) * | 2000-02-03 | 2005-11-30 | Nuvelo Inc | NUCLEIC ACIDS AND POLYPEPTIDES |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| WO2001075166A2 (en) | 2000-03-31 | 2001-10-11 | Genentech, Inc. | Compositions and methods for detecting and quantifying gene expression |
| WO2001090304A2 (en) * | 2000-05-19 | 2001-11-29 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| EP1330543A4 (en) * | 2000-10-02 | 2006-03-29 | Bayer Ag | IN CANCER TISSUE, EXPRESSED NUCLEIC ACID SEQUENCES DIFFERENTIATE |
| US20020137081A1 (en) * | 2001-01-08 | 2002-09-26 | Olga Bandman | Genes differentially expressed in vascular tissue activation |
| JP2005500008A (ja) | 2001-01-19 | 2005-01-06 | インサイト・ゲノミックス・インコーポレイテッド | 受容体および膜結合タンパク質 |
| WO2003010327A2 (en) * | 2001-02-21 | 2003-02-06 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
| WO2003016475A2 (en) * | 2001-08-14 | 2003-02-27 | The General Hospital Corporation | Nucleic acid and amino acid sequences involved in pain |
| US6489153B1 (en) * | 2001-10-31 | 2002-12-03 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1575480A4 (en) * | 2002-02-22 | 2008-08-06 | Genentech Inc | COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO THE IMMUNE SYSTEM |
| JP2004121218A (ja) * | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| US7118865B2 (en) * | 2002-08-16 | 2006-10-10 | Regents Of The University Of Minnesota | Methods for diagnosing severe systemic lupus erythematosus |
| EP2116551A1 (en) * | 2002-09-11 | 2009-11-11 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| CA2499843A1 (en) * | 2002-09-25 | 2004-04-08 | Genentech, Inc. | Novel compositions and methods for the treatment of psoriasis |
| US20070224201A1 (en) * | 2002-10-02 | 2007-09-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| EP1578368A4 (en) * | 2002-11-12 | 2008-01-23 | Genentech Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF RHEUMATOID ARTHRITIS |
| EP1572116A4 (en) * | 2002-11-26 | 2007-12-12 | Genentech Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES |
| US20040191818A1 (en) * | 2003-02-26 | 2004-09-30 | O'toole Margot Mary | Compositions and methods for diagnosing and treating autoimmune diseases |
-
2004
- 2004-03-02 AU AU2004293369A patent/AU2004293369A1/en not_active Abandoned
- 2004-03-02 EP EP04775826A patent/EP1599498A2/en not_active Withdrawn
- 2004-03-02 JP JP2006532309A patent/JP2008500009A/ja active Pending
- 2004-03-02 CA CA002518101A patent/CA2518101A1/en not_active Abandoned
- 2004-03-02 US US10/547,578 patent/US7749695B2/en not_active Expired - Fee Related
- 2004-03-02 WO PCT/US2004/006460 patent/WO2005051988A2/en not_active Ceased
-
2009
- 2009-10-22 US US12/589,398 patent/US20110142841A1/en not_active Abandoned
-
2010
- 2010-04-08 JP JP2010089887A patent/JP2010207229A/ja active Pending
-
2011
- 2011-05-05 AU AU2011202082A patent/AU2011202082A1/en not_active Abandoned
-
2013
- 2013-06-10 JP JP2013121971A patent/JP2013240329A/ja active Pending